MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Clinical exams alone can be inconclusive for RP68, while a gene capture sequencing panel has identified novel mutations and pointed patients toward trials.
Aortic root dilation, skeletal changes and distinctive facial features mark this autosomal dominant disorder, which overlaps clinically with Marfan syndrome.
Three developmental anomalies define this rare syndrome: sacral agenesis, abnormal ossification of the vertebral bodies and a persistent notochordal canal.
Mutations in MAGEL2 underlie this rare disorder, which brings developmental delay, intellectual disability and physical anomalies. Testing confirms it and guides care.
Schwannomas on nerves throughout the body cause chronic pain and neurological problems, usually without the vestibular tumors and hearing loss of related disorders.
Explore how genetic testing aids in diagnosing Severe Combined Immunodeficiency due to IKK2 deficiency, offering early intervention and personalized treatments.
When the LCK gene is mutated, T-cell signaling fails and infections, inflammation and autoimmunity follow; testing confirms the diagnosis and identifies carriers.
Explore how genetic testing aids in the early detection and personalized treatment of SAM syndrome, enhancing patient outcomes and guiding family planning decisions.